Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22921
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPeverelle, Matthew R-
dc.contributor.authorAsadi, Khashayar-
dc.contributor.authorDe Cruz, Peter P-
dc.date2020-03-31-
dc.date.accessioned2020-04-14T04:00:53Z-
dc.date.available2020-04-14T04:00:53Z-
dc.date.issued2020-03-31-
dc.identifier.citationJournal of Crohn's & colitis 2020; online first: 31 March-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/22921-
dc.language.isoeng-
dc.subjectCrohn’s disease-
dc.subjectLiver transplantation-
dc.subjectUstekinumab-
dc.titleUstekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient.-
dc.typeJournal Article-
dc.identifier.journaltitleJournal of Crohn's & colitis-
dc.identifier.affiliationDepartment of Anatomical Pathology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Gastroenterology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1093/ecco-jcc/jjaa062-
dc.identifier.orcid0000-0003-0136-6699en
dc.identifier.orcid0000-0002-3399-7236en
dc.identifier.pubmedid32232397-
dc.type.austinJournal Article-
Appears in Collections:Journal articles
Show simple item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.